Here are just a few of the latest enhancements to the Dexcom G6 app.
Real-time glucose data can be shared with up to 10 followers, increasing a patient’s circle of support.
Patient reports can be launched directly from the Dexcom G6 app, providing easy-to-access reports that you and your patient can review during office visits.
In addition to the current 2- and 6-hour reminders, a notification to replace the sensor is now sent to patients 24 hours prior to expiration.
Patients can ask Siri to read their glucose numbers and trend rate (when available) as well as display their trend graph for quick and convenient access to glucose data (iOS devices only).
For more information, visit www.dexcom.com
*If your glucose alerts and readings from the Dexcom G6 do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.
BRIEF SAFETY STATEMENT: Failure to use the Dexcom G6 Continuous Glucose Monitoring System (Dexcom G6) and its components according to the instructions for use provided with your device and available at https://www.dexcom.com/safety-information and to properly consider all indications, contraindications, warnings, precautions, and cautions in those instructions for use may result in you missing a severe hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose) occurrence and/or making a treatment decision that may result in injury. If your glucose alerts and readings from the G6 do not match symptoms or expectations or you’re taking over the recommended maximum dosage amount of 1000mg of acetaminophen every 6 hours, use a blood glucose meter to make diabetes treatment decisions. Seek medical advice and attention when appropriate, including for any medical emergency.
Dexcom, Dexcom CLARITY, and Dexcom G6 are registered trademarks of Dexcom, Inc. in the U.S., and may be registered in other countries.
First and only single-use, professional CGM system with blinded or unblinded mode
Dexcom, Inc. (NASDAQ:DXCM) announced today the U.S. Food and Drug Administration (FDA) has cleared the Dexcom G6 Pro Continuous Glucose Monitoring (CGM)...
Join Dexcom at the upcoming AADE conference from August 9-12, 2019, in Houston, TX. Attendees are invited to attend a special Dexcom product theater and participate in the Dexcom DANA Technology Workshop (details for both...
The ATDC conference will be held on July 11-14, 2019 in Keystone, CO. This event will focus on using new technologies to overcome challenges in day-to-day management of diabetes. Clinical studies and the benefits of Dexcom...